KCTD12 promotes G1/S transition of breast cancer cell through activating the AKT/FOXO1 signaling.
Run-Yi YeXia-Ying KuangHui-Juan ZengNan ShaoYing LinShen-Ming WangPublished in: Journal of clinical laboratory analysis (2020)
Our study inferred that downregulation of KCTD12 can be a novel factor for poor prognosis in breast cancer.